Vaccination against herpes zoster is associated with lower risks for heart disease, dementia, and mortality among adults aged 50 years and older.

Replimune Group (($REPL)) announced an update on their ongoing clinical study. Replimune Group is conducting a Phase 1B/2 study titled ‘An ...

Objectives To compare the effectiveness of different exercise interventions in improving sleep quality and alleviating insomnia severity among patients with insomnia. Design Our study design was a ...

Abstract: Exploring brain function is crucial for unraveling the pathological mechanism underlying stroke. While most studies focus on brain function and emphasize dynamic connections and interactions ...

An international research team has determined the first high-resolution structures of the herpes simplex virus origin-binding ...

A second study presented at IDWeek showed that shingles vaccination decreases the risk for death and heart disease — this time among people living with HIV.“Shingles is usually thought of as a painful ...

A study of an urban US population reports a sharp decline in dermatologic disease in people with newly diagnosed HIV and ...

Shingles vaccine recipients who had a breakthrough infection experienced no reduction in all-cause dementia compared with those who received a pneumonia vaccine. They trended toward fewer post-zoster ...

The company’s technology, a modified herpes simplex virus used to deliver gene therapies, was given the FDA’s new designation ...

There is more evidence that shingles vaccination significantly decreases the risk for heart disease, dementia and death among ...

A genetically engineered herpes virus may offer a new and effective treatment for advanced melanoma, providing hope for ...